In the ongoing phase 1 study, GIM-407 will be administered orally to healthy volunteers to further characterize the safety, tolerability, and pharmacokinetics. Data collected from this study will help ...
Keeping your room cool, dark, and quiet can help create an environment that’s ideal for falling asleep quickly. Investing in some blackout curtains, a white noise machine or earplugs, and comfy ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a biotechnology company developing transformational opioid-free intracellularly-delive ...
ResVita Bio, a synthetic biology company, announces that the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) at the NIH has awarded the company a $2.03M Phase II Small ...
DELRAY BEACH, FL / ACCESSWIRE / September 24, 2024 / Adolore BioTherapeutics, Inc., ("Adolore" or the "Company"), a ...
Leading medical centers will compare three first-line treatments for postpartum urinary incontinence NEWTON, Mass., September ...
Funding: This work was funded by the United States National Institutes of Health (K23MH121657, R21MH126271), Brain and Behavior Research Foundation Young Investigator Grant, Baszucki Brain Research ...
The exorbitant cost of the failing health of our kids, the needless suffering and death, can be ended by a Kennedy Commission ...